tirzepatide and dementia GLP-1 Drugs Linked to Lower Stroke Risk - European Medical Journal GLP-1 Drugs Linked to Lower Dementia and Stroke Risk Prevention of Dementia with GLP-1

Patients who are about to begin or who have recently begun taking any GLP-1 medication should thus have a dilated eye examination to assess risk factors for developing NAION

Understanding the broader context of peptide safety considerations helps frame these specific drug interaction concerns within the larger picture of responsible peptide use

5-10 GLP-1 agonist medications can help manage hunger and blood sugar in several ways, including signaling to the brain to help you feel full sooner, slowing down how quickly food leaves your stomach, helping the pancreas release insulin after meals, and reducing the release of glucagon a hormone that raises blood sugar

They also include some Hungryroot-brand items that emphasize healthy versions of kitchen classics (like the chickpea cookie dough or cashew-based Parmesan sauce), prepared proteins, and even ready-to-eat meals

What we do know is that the rate of weight loss seems to play a role

These cases were relatively rare and not always directly linked to the medication